From Signaling Pathways to Diagnosis and Therapy of Cancers

Targeted therapy of various cancers is far from being well-understood and implemented in daily practice. There is an urgent need to understand the cancer cells, from pathways to diagnosis and therapy aspects. The clinical implications of understanding the Signaling Pathways and new data regarding diagnosis and therapy are also important.

The aims of this Special Issue are the following: to attract chemists, doctors, and researchers who are focused on cancer research and the Signaling Pathways are involved in the diagnosis and therapy of patients. We intend to attract papers which can be integrated into a common purpose: understanding cancers, from molecular basis to the malignant phenotypes. Original papers and review articles are welcomed if they are fit for the proposal aims.

Potential topics include but are not limited to the following:

• Signaling Pathways used for early detection of cancer-related antibodies in biological fluids and tissues
• Experimental and clinical studies aimed to detect the particularities of the Signaling Pathways
• New Signaling Pathways involved in tumorigenesis and tumor invasion
• Old and new concepts of screening of cancers based on Signaling Pathways
• Systematic reviews on the latest information regarding classic Signaling Pathways

Please submit your manuscripts by May 31, 2021. Contributions will receive prompt and thorough peer review. Please refer to our Instructions for Authors before submitting your manuscript for consideration.

Please direct Editorial questions to our Editor-in-Chief, Dr. Martin Brechbiel at mbrechbiel@liebertpub.com or to Dr. Xiangya Ding at dingxy@njmu.edu.cn